The total triterpenes of Ganoderma lucidum contains at least 15 triterpenes, and the researchers also found a single triterpenoid compound, which inhibits the activity of renal vesicles, which is composed of ethyl ganoderate C2, whose chemical structure is as following
Unfortunately, the content of this active triterpenoid compound is too small to be carried out in animal experiments, not to mention the clinical application.
So from a realistic point of view, mixed with many components of the total triterpenoid fungus of reishi mushroom, is the ideal choice for patients at this stage, and the role of more and better!
Researchers in their published papers mentioned that the pathogenesis of polycystic kidney disease, and kidney tumors have the same place. Many studies have shown that total triterpenoids of Ganoderma lucidum can be through a variety of mechanisms for cancer cells, and these anti-cancer mechanisms, may also contribute to the control of polycystic kidney disease.
Although the total triterpenoids of Ganoderma lucidum can not change the innate gene mutation, but through the maintenance of normal cells to reduce the negative effects of gene mutations, polycystic kidney disease for the normal life of patients with more opportunities.
Just do not forget that this study uses the total triterpenoids of Ganoderma lucidum, is the substance of the Ganoderma lucidum fruiting body, there is a need, do not admit it!